Medical-AI trial: detecting brain aneurysms from head MRI (TOF-MRA) with AI (RDX-Aneurysm) — testing performance against misses (NCT07655635)
A retrospective, multicenter, case-control study evaluating the standalone performance of RDX-Aneurysm, a computer-assisted detection software, in finding and marking saccular intracranial (brain) aneurysms on adult head time-of-flight MR angiography (TOF-MRA). About 550 exams: ~250 positive with a confirmed aneurysm 3 mm or larger and ~300 negative. The primary outcome is lesion-level sensitivity for saccular aneurysms 3 mm or greater.
Trial overview (primary data)
- StatusActive, not recruiting
- ConditionsIntracranial Aneurysm
- SponsorTaipei Medical University Shuang Ho Hospital
- Target enrollment550 participants
- Period2024-07-20 〜 2027-06-30
Key points
- A retrospective, multicenter, case-control study of the standalone performance of CADe software RDX-Aneurysm in detecting saccular brain aneurysms on adult head TOF-MRA.
- About 550 exams: ~250 positive with a confirmed aneurysm 3 mm or larger and ~300 negative with none.
- The primary outcome is lesion-level sensitivity for saccular aneurysms 3 mm or greater.
- Brain aneurysms can rupture into subarachnoid hemorrhage; small or ambiguous ones are easily missed.
- AI marking suspicious sites could act as a second set of eyes; a retrospective standalone-performance evaluation, not an establishment of reader replacement or rupture prevention.
- About 250 positive and 300 negative cases of some 550, with lesion-level sensitivity for aneurysms of 3 mm or more.
1What a missed brain aneurysm costs
A brain (intracranial) aneurysm is a balloon-like bulge in the wall of a brain vessel; most are asymptomatic, but a rupture causes the serious event of subarachnoid hemorrhage. Found before rupture, it can be watched or treated preventively. TOF-MRA, a form of brain MRI that depicts vessels from blood flow without contrast, is used to find aneurysms, but small or ambiguous ones are easily missed.
That is where computer-assisted detection (CADe) software, which analyzes the image and points to suspected aneurysm sites, comes in.
2A retrospective, multicenter performance study
This study evaluates the performance of that CADe software, RDX-Aneurysm, as a retrospective, multicenter, case-control study.
Per the registry summary, it evaluates the standalone performance of RDX-Aneurysm in detecting and marking suspected saccular (sac-like) intracranial aneurysms on adult head TOF-MRA. The evaluation includes about 550 exams: roughly 250 positive exams with at least one reference-confirmed saccular aneurysm 3 mm or larger, and roughly 300 negative exams with no confirmed aneurysm. The primary outcome is lesion-level sensitivity for saccular aneurysms 3 mm or greater.
3Positive and negative cases collected separately
The study takes a case-control design, gathering positive and negative cases separately in advance. The breakdown shows the character of the design.
The primary endpoint is lesion-level sensitivity for saccular intracranial aneurysms of 3 mm or more. Most aneurysms are asymptomatic, while rupture brings subarachnoid haemorrhage. TOF-MRA is used to find them, and small ones or confusing locations are easily missed, so AI marking suspicious sites could act as a second pair of eyes.
Why it matters
Missing a brain aneurysm can lead to a preventable rupture and is an important reading challenge. AI marking suspicious sites could act as a second set of eyes to reduce misses; a case-control design with lesion-level sensitivity aptly measures a detection software (this study is a retrospective standalone-performance evaluation, not an establishment of reader replacement or rupture prevention).
FAQ
What is TOF-MRA?
Does the AI replace the radiologist reading?
Sources (primary)
Source: ClinicalTrials.gov (U.S. NIH/NLM, public domain). This site does not provide medical advice. Verify the latest and exact details with the official source. This site is not endorsed or certified by the NIH/NLM.
- ClinicalTrials.gov (study record, original)
- NCT ID: NCT07655635